Lazard Asset Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Lazard Asset Management’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-74,500	Closed	-$2.09M	–	1083
2016 Q3	$2.09M	Sell	74,500 -16,400	-18%	-$550K	﹤0.01%	619
2016 Q2	$3.18M	Hold	90,900	–	–	0.01%	564
2016 Q1	$2.49M	Hold	90,900	–	–	0.01%	586
2015 Q4	$3.11M	Buy	+90,900	New	+$2.84M	0.01%	596
2015 Q3	–	Sell	-190,630	Closed	-$8.53M	–	1191
2015 Q2	$8.53M	Sell	190,630 -91,800	-33%	-$3.45M	0.02%	422
2015 Q1	$9.77M	Buy	282,430 +88,300	+45%	+$2.4M	0.02%	393
2014 Q4	$5.31M	Buy	+194,130	New	+$4.71M	0.01%	533

Other funds holding DPLO

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

HIM

Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Lazard Asset Management's DPLO Position: Q4 2016 in Review

Lazard Asset Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2016, closing a stake of 74,500 shares — an estimated $2.09M sold.

Lazard Asset Management first reported a position in DPLO in Q4 2014 and held it in 7 quarters. The position peaked at $9.77M in Q1 2015. 174 funds tracked by Wall St. Rank hold DPLO as of Q4 2016.

Lazard Asset Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2016 after selling out during the quarter.
Lazard Asset Management sold 74,500 DIPLOMAT PHARMACY, INC. shares in Q4 2016, an estimated $2.09M.
Lazard Asset Management first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 7 quarters.
Lazard Asset Management's DIPLOMAT PHARMACY, INC. position peaked at $9.77M in Q1 2015.
174 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2016.

Based on Lazard Asset Management's 13F filing for Q4 2016, filed 13 Feb 2017.